Bank of America’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,074,972
| Closed | -$405M | – | 7768 |
|
|
2019
Q3 | $405M | Buy |
4,074,972
+274,613
| +7% | +$26.1M | 0.06% | 306 |
|
|
2019
Q2 | $351M | Buy |
3,800,359
+701,531
| +23% | +$66.6M | 0.05% | 335 |
|
|
2019
Q1 | $292M | Sell |
3,098,828
-2,113,604
| -41% | -$185M | 0.05% | 358 |
|
|
2018
Q4 | $334M | Sell |
5,212,432
-699,145
| -12% | -$51.6M | 0.06% | 313 |
|
|
2018
Q3 | $529M | Buy |
5,911,577
+138,659
| +2% | +$12.3M | 0.08% | 252 |
|
|
2018
Q2 | $458M | Sell |
5,772,918
-578,224
| -9% | -$48M | 0.08% | 259 |
|
|
2018
Q1 | $567M | Sell |
6,351,142
-1,996,626
| -24% | -$192M | 0.1% | 216 |
|
|
2017
Q4 | $871M | Sell |
8,347,768
-4,520,195
| -35% | -$510M | 0.15% | 158 |
|
|
2017
Q3 | $1.88B | Buy |
12,867,963
+3,139,662
| +32% | +$428M | 0.3% | 77 |
|
|
2017
Q2 | $1.26B | Sell |
9,728,301
-329,748
| -3% | -$40.4M | 0.25% | 99 |
|
|
2017
Q1 | $1.25B | Buy |
10,058,049
+321,052
| +3% | +$38.4M | 0.25% | 100 |
|
|
2016
Q4 | $1.13B | Buy |
9,736,997
+120,186
| +1% | +$13.4M | 0.24% | 99 |
|
|
2016
Q3 | $1.01B | Sell |
9,616,811
-22,146
| -0.2% | -$2.4M | 0.22% | 111 |
|
|
2016
Q2 | $951M | Sell |
9,638,957
-242,321
| -2% | -$25.1M | 0.22% | 113 |
|
|
2016
Q1 | $989M | Sell |
9,881,278
-1,058,073
| -10% | -$109M | 0.24% | 98 |
|
|
2015
Q4 | $1.31B | Buy |
10,939,351
+758,720
| +7% | +$87.8M | 0.31% | 68 |
|
|
2015
Q3 | $1.1B | Buy |
10,180,631
+5,155,873
| +103% | +$640M | 0.27% | 87 |
|
|
2015
Q2 | $582M | Sell |
5,024,758
-1,803,998
| -26% | -$206M | 0.19% | 115 |
|
|
2015
Q1 | $787M | Buy |
6,828,756
+2,019,494
| +42% | +$241M | 0.26% | 77 |
|
|
2014
Q4 | $538M | Sell |
4,809,262
-213,631
| -4% | -$22.5M | 0.19% | 109 |
|
|
2014
Q3 | $476M | Sell |
5,022,893
-1,178,133
| -19% | -$106M | 0.15% | 140 |
|
|
2014
Q2 | $533M | Sell |
6,201,026
-975,356
| -14% | -$74.2M | 0.17% | 129 |
|
|
2014
Q1 | $501M | Buy |
7,176,382
+793,598
| +12% | +$62.8M | 0.19% | 116 |
|
|
2013
Q4 | $539M | Buy |
6,382,784
+2,020,102
| +46% | +$160M | 0.19% | 105 |
|
|
2013
Q3 | $336M | Buy |
4,362,682
+781,176
| +22% | +$54.7M | 0.13% | 165 |
|
|
2013
Q2 | $209M | Buy |
+3,581,506
| New | +$216M | 0.09% | 212 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Bank of America's CELG Position: Q4 2019 in Review
Bank of America sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,074,972 shares — an estimated $405M sold.
Bank of America first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.88B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bank of America reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bank of America sold 4,074,972 Celgene Corp shares in Q4 2019, an estimated $405M.
- Bank of America first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Bank of America's Celgene Corp position peaked at $1.88B in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.